What are second line treatments in lower-risk MDS with anemia?
A roundtable discussion on anemia management in myelodysplastic syndromes, featuring moderator Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center;
Meetings / Conferences
66th American Society of Hematology Annual Meeting & Exposition
News
Roundtable Discussions
MDS Roundtable
Meetings / Conferences
66th American Society of Hematology Annual Meeting & Exposition
Roundtable Discussions
MDS Roundtable
How do you treat patients with MDS and anemia?
A roundtable discussion on anemia management in myelodysplastic syndromes (MDS), featuring moderator Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center;
Meetings / Conferences
66th American Society of Hematology Annual Meeting & Exposition
News
Roundtable Discussions
MDS Roundtable
What novel therapies were discussed at ASH 2024?
A roundtable discussion on anemia management in myelodysplastic syndromes (MDS), Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center; Amy
Meetings / Conferences
2025 Tandem Meetings
News
Hematologic cancer survivors show accelerated brain aging
Survivors of hematologic cancers might experience worse neurocognitive functioning compared with their healthy counterparts, according to an abstract presented at the 2025 Transportation
News
Society Updates
Save the date: SOHO Israel 2025
Save the date: 3rd SOHO Israel Annual Meeting SOHO Israel has announced that its 3rd SOHO-Israel meeting and 9th International Davidoff conference entitled:
Leukemia
Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Neoplasms
News
Society Updates
Abstract submissions now open for SOHO 2025
Delegates and attendees are invited to submit an abstract for a poster or oral presentation for the Thirteenth Annual Meeting of the Society
Meetings / Conferences
2025 Tandem Meetings
ACROBAT interim results support AlloHeme for relapse prediction in AML, MDS
Interim results of the ACROBAT study suggest that increasing microchimerism and loss of complete chimerism may indicate relapse risk in patients with acute
Leukemia
Chronic Lymphocytic Leukemia
News
Fixed-duration acalabrutinib-venetoclax combinations outperform SOC in treatment-naïve CLL
Fixed-duration acalabrutinib plus venetoclax with or without obinutuzumab improved progression-free survival over fludarabine-cyclophosphamide-rituximab or bendamustine-rituximab in treatment-naïve chronic lymphocytic leukemia (TN CLL), according
Chronic Lymphocytic Leukemia
Lymphoma
Indolent B-Cell Lymphomas
Multiple Myeloma
Is a stronger flu vaccine better for blood cancer patients?
A correspondence published in The New England Journal of Medicine suggests that a stronger flu vaccine provided little benefit compared with the regular
News
Society Updates
Keynote speakers announced for the Thirteenth Annual Meeting of the Society of Hematologic Oncology
Three keynote speakers have been chosen for the Thirteenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2025). The speakers include Sagar